/Investor DB

Illumina Accelerator

Acceleratoroperating company · company profile

San Diego · Pre-Seed–Seed · 4 people tracked

Find your way into Illumina Accelerator

Each arrow is one introduction. Sign up to fill in the first one.

301 people can intro you to Frances

Ask Jeremy Loh to introduce you to Frances H. Arnold

You →Jeremy · together at JBEI →Frances

237 people can intro you to Ankur

Ask Jamie Chen to introduce you to Ankur Dhingra

You →Jamie · together at Summit Therapeutics →Ankur

46 people can intro you to Sue

Ask Sam Okafor to introduce you to Sue Siegel

You →Sam · together at Obvious Ventures →Sue

Sign up to find every way you can get introduced to Illumina Accelerator

  • Your email: who you already know at Illumina Accelerator, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Illumina Accelerator team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

✨ Fox Verdict
Sign up to see your fit

Investment thesis

Illumina for Startups aims to accelerate innovation in the genomics entrepreneurial community by partnering with venture investors and entrepreneurs to create, launch, and grow genomics startups. It advances breakthrough genomics applications spanning therapeutics, diagnostics, agriculture, synthetic biology, software, and direct-to-consumer uses. The program offers grants that let entrepreneurs run proof-of-concept next-generation sequencing experiments at selected Illumina sites, providing access to MiSeq, NextSeq, and NovaSeq systems plus Illumina reagents, technical advice, experiment-planning meetings with scientists, and connections to subject-matter experts. The former Illumina Accelerator, which operated in the San Francisco Bay Area since 2014 and Cambridge, UK since 2020, joined Illumina Ventures in 2023 and relaunched as Illumina Ventures Labs.

Source: firm website, verified Sep 27, 2026.

Stage
Pre-Seed–Seed
HQ
San Diego, CA, US
Instruments
Grants
Founded
2014
Last 12 months
2 investments
Portfolio companies
12

Team · 4 people

from curated

What they invest in

from 5 of 12 portfolio companies

AI & Machine Learning ×3Biotech ×3Digital Health ×3Healthtech ×3Deep Tech ×2Direct to Consumer ×1FemTech ×1Marketing Tech ×1

HQs:United States×2United Kingdom×1

Portfolio companies · 12 tracked

alumni founders can tell you what the program is really like

By year:2026 · 22021 · 13 dated

NonExomicsnonexomics.comin𝕏Apr 2021✓ verified

NonExomics is a drug discovery company that uses a machine learning platform integrating genomics, transcriptomics, and proteomics to identify novel "noncanonical" proteins encoded across the entire human genome, including the previously unstudied 98% "dark genome." It has cataloged hundreds of thousands of such proteins and thousands of novel druggable targets associated with over 1,300 human diseases for therapeutic development.

AI & Machine LearningBiotechDeep TechHealthtechActon, US

Ruchi Chauhan(Director)

Co-investorsFormation Venture Engineering

BioAmp Diagnosticsbioampdx.com

BioAmp Diagnostics develops a chemistry-based rapid diagnostic pipeline (DETECT: Dual-Enzyme Trigger-Enabled Cascade Technology) that delivers infection results in minutes to guide antibiotic prescribing, initially targeting complicated urinary tract infections.

BiotechDigital HealthMedical DevicesSan Carlos, US

Tara DeBoer(Chief Executive Officer)inAngel Resendez(Director of Chemistry - Small Molecule Discovery, CSIO)in

Co-investorsBerkeley Angel NetworkBlue Bear Ventures

Illuminailluminaventures.com

Illumina Ventures is a venture capital firm focused on genomics and precision health, investing in early-stage companies developing breakthrough science and technology to improve human health.

AI & Machine LearningBiotechDeep TechDigital HealthHealthtech

Co-investorsBeast Ventures

Junoheyjuno.coin𝕏Jul 2026 · $3.8M

Juno is a research platform that runs unscripted, asynchronous qualitative interviews with real people and analyzes the responses at scale, connecting themes to source quotes.

AI & Machine LearningMarketing TechSaaS

Michelle Gilmore(CEO)

Co-investorsBlackbird VenturesFlying Fox VenturesAda VenturesArtesianEntrepreneur First

Juno Biojuno.bio𝕏Jul 2026 · $3.8M

Juno offers an at-home vaginal microbiome test paired with results, treatment plans, and support from OB-GYNs and researchers, aimed at helping people manage vaginal symptoms and infections.

Digital HealthDirect to ConsumerFemTechHealthtechLondon, GB

Hana Janebdar(CEO)inLeighton Turner(CTO)in

Co-investorsAI SeedEntrepreneur FirstAda VenturesArtesian

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

About Us.HtmlContact Us.HtmlCustomer Engagement Center.HtmlDoing Business With Illumina.HtmlNews Center.HtmlOverviewSkip to content

Portfolio news

latest coverage across their companies
Juno Bio Raises $3.8M in Funding

Juno Bio · finsmes.com · Jul 17, 2026

Frequently asked questions

How many investments has Illumina Accelerator made?
Illumina Accelerator has 12 tracked investments, including 2 dated in the last 24 months.
What stage does Illumina Accelerator invest at?
Illumina Accelerator invests at the Pre-Seed, Seed stages.
What sectors does Illumina Accelerator focus on?
Illumina Accelerator focuses on AgTech, Biotech, Deep Tech, Digital Health, Healthtech.
Where is Illumina Accelerator located?
Illumina Accelerator is headquartered in San Diego, US.

Images

Illumina Accelerator photo

Similar investors

Featured in lists